Sen Claire McCaskill (D, Missouri) has launched a Senate investigation into whether 5 drug companies marketed their opioid painkillers in a manner that may have contributed to the nation’s opioid epidemic.

In
letters to the companies, which include Mylan, Depomed, INSYS Therapeutics, Purdue Pharma, and Johnson & Johnson’s Janssen division, McCaskill demanded internal documents relating to the firms’ marketing tactics, studies the companies conducted that might have alerted them to the risk of addiction and lethal overdose, behind-the-scenes efforts to block increased regulation, and sales quotas that may have led drug representatives to use kickbacks to encourage physicians to prescribe the drugs.

 


Comments


Your comment will be posted after it is approved.


Leave a Reply